Experimental studies in mice have produced data suggesting that myostatin inhibitor such as ACE-031 may induce maximal skeletal muscle growth. Although these findings are in their early stages and require further investigation, they imply that comprehensive muscle protection in conditions characterized by muscle wasting may require a multifaceted approach. This approach may combine interventions that enhance muscle growth, such as growth hormone and IGF-1, with strategies that mitigate muscle wasting, such as ACE-031.(5)
